Plontke S K, Rahne T, Pfister M, Götze G, Heider C, Pazaitis N, Strauss C, Caye-Thomasen P, Kösling S
Klinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Hals-Chirurgie, Martin-Luther-Universität Halle-Wittenberg, Universitätsmedizin Halle, Ernst-Grube-Str. 40, 06120, Halle (Saale), Deutschland.
HNO Sarnen, Sarnen, Schweiz.
HNO. 2017 May;65(5):419-433. doi: 10.1007/s00106-017-0361-9.
Intralabyrinthine schwannomas (ILS) are a rare differential diagnosis of sudden hearing loss and vertigo. In an own case series of 12 patients, 6 tumors showed an intracochlear, 3 an intravestibular, 1 a transmodiolar including the cerebello-pontine angle (CPA), 1 a transotic including the CPA and 1 a multilocular location. The tumors were removed surgically in 9 patients, whereas 3 patients opted for a "wait-and-test-and-scan" strategy. Of the surgical patients, 3 underwent labyrinthectomy and cochlear implant (CI) surgery in a single stage procedure; 1 patient received extended cochleostomy with CI surgery; 3 underwent partial or subtotal cochleoectomy, with partial cochlear reconstruction and CI surgery (n = 1) or implantation of electrode dummies for possible later CI following repeated MRI follow-up (n = 2); and in 2 patients, the tumors of the internal auditory canal and cerebellopontile angle exhibiting transmodiolar or transmacular growth were removed by combined translabyrinthine-transotic resection. For the intracochlear tumors, vestibular function could mostly be preserved after surgery. In all cases with CI surgery, hearing rehabilitation was successful, although speech discrimination was limited for the case with subtotal cochleoectomy. Surgical removal of intracochlear schwannomas via partial or subtotal cochleoectomy is, in principle, possible with preservation of vestibular function. In the authors' opinion, radiotherapy of ILS is only indicated in isolated cases. Provided performed early enough, cochlear implantation after surgical removal of ILS is an option for auditory rehabilitation, thus representing-in contrast to the "wait-and-test-and-scan" strategy-a therapeutic approach.
迷路内神经鞘瘤(ILS)是突发性听力损失和眩晕的一种罕见鉴别诊断。在作者自己的一个包含12例患者的病例系列中,6例肿瘤位于耳蜗内,3例位于前庭内,1例为经蜗轴型包括小脑脑桥角(CPA),1例为经耳型包括CPA,1例为多房性。9例患者的肿瘤通过手术切除,而3例患者选择了“等待 - 检测 - 扫描”策略。在接受手术的患者中,3例在一期手术中进行了迷路切除术和人工耳蜗(CI)植入手术;1例患者接受了扩大的耳蜗造口术并植入CI;3例接受了部分或次全耳蜗切除术,其中1例进行了部分耳蜗重建和CI植入,2例在多次MRI随访后植入电极假件以便日后可能植入CI;2例患者通过联合经迷路 - 经耳切除术切除了表现为经蜗轴型或经黄斑型生长的内耳道和小脑脑桥角肿瘤。对于耳蜗内肿瘤,术后前庭功能大多可以保留。在所有接受CI手术的病例中,听力康复均成功,尽管次全耳蜗切除术患者的言语辨别能力有限。原则上,通过部分或次全耳蜗切除术手术切除耳蜗内神经鞘瘤并保留前庭功能是可行的。作者认为,ILS的放射治疗仅适用于个别病例。如果手术切除ILS后尽早进行人工耳蜗植入,是听觉康复的一种选择,因此与“等待 - 检测 - 扫描”策略相比,这是一种治疗方法。